# Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer

> **NCT01967862** · NA · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 54 (actual)

## Conditions studied

- Recurrent Prostate Cancer

## Interventions

- **PROCEDURE:** computed tomography
- **PROCEDURE:** bone scan
- **PROCEDURE:** 3-Tesla magnetic resonance imaging
- **PROCEDURE:** diffusion-weighted magnetic resonance imaging
- **RADIATION:** fluorine F 18 sodium fluoride
- **PROCEDURE:** computed tomography
- **PROCEDURE:** positron emission tomography
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01967862
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2018-09-17
- **Final completion:** 2018-09-17
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01967862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01967862, "Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01967862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*